A survey of eMedia-delivered interventions for

schizophrenia used in randomized controlled trials by Naeem, Farooq et al.
Naeem, Farooq and Munschi, Tariq and Xiang, Shuo 
and Yang, Megan and Shokraneh, Farhad and Syed, 
Yumeen and Ayub, Muhammad and Adams, Clive E. 
and Farooq, Saeed (2017) A survey of eMedia-delivered 
interventions for schizophrenia used in randomized 
controlled trials. Neuropsychiatric Disease and 
Treatment, 13 . pp. 233-243. ISSN 1178-2021 
Access from the University of Nottingham repository: 
http://eprints.nottingham.ac.uk/40935/1/NDT-115897-a-survey-of-emedia-delivered-
interventions-for-schizophrenia_012717.pdf
Copyright and reuse: 
The Nottingham ePrints service makes this work by researchers of the University of 
Nottingham available open access under the following conditions.
This article is made available under the Creative Commons Attribution Non-commercial 
licence and may be reused according to the conditions of the licence.  For more details see: 
http://creativecommons.org/licenses/by-nc/2.5/
A note on versions: 
The version presented here may differ from the published version or from the version of 
record. If you wish to cite this item you are advised to consult the publisher’s version. Please 
see the repository url above for details on accessing the published version and note that 
access may require a subscription.
For more information, please contact eprints@nottingham.ac.uk
© 2017 Naeem et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php 
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you 
hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission 
for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Neuropsychiatric Disease and Treatment 2017:13 233–243
Neuropsychiatric Disease and Treatment Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
233
O r i g i N a l  r e s e a r c h
open access to scientific and medical research
Open access Full Text article
http://dx.doi.org/10.2147/NDT.S115897
a survey of eMedia-delivered interventions for 
schizophrenia used in randomized controlled trials
Farooq Naeem1
Tariq Munshi1
shuo Xiang1
Megan Yang1
Farhad shokraneh2
Yumeen syed3
Muhammad ayub1
clive e adams4
saeed Farooq5
1Department of Psychiatry, Queens 
University, Kingston, ON, canada; 
2institute of Mental health, 
Nottingham, UK; 3Trenlogic, Toronto, 
ON, canada; 4Nottingham University, 
Nottingham, 5Keele University, 
stafford, UK
Background: Randomized trials evaluating electronic Media (eMedia) delivery of interventions are 
increasingly frequent in mental health. Although a number of reviews have reported efficacy of these 
interventions, none has reviewed the type of eMedia interventions and quality of their description. 
We therefore decided to conduct a survey of eMedia-delivered interventions for schizophrenia.
Methods: We surveyed all relevant trials reliably identified in the Cochrane Schizophrenia Group’s 
comprehensive register of trials by authors working independently. Data were extracted regarding 
the size of the trial, interventions, outcomes and how well the intervention was described.
Results: eMedia delivery of interventions is increasingly frequent in trials relevant to the 
care of people with schizophrenia. The trials varied considerably in sample sizes (mean =123, 
median =87, range =20–507), and interventions were diverse, rarely evaluating the same 
approaches and were poorly reported. This makes replication impossible. Outcomes in these 
studies are limited, have not been noted to be chosen by end users and seem unlikely to be easy 
to apply in routine care. No study reported on potential adverse effects or cost, end users satisfac-
tion or ease of use. None of the papers mentioned the use of CONSORT eHealth guidelines.
Conclusion: There is a need to improve reporting and testing of psychosocial interventions 
delivered by eMedia. New trials should comply with CONSORT eHealth guidance on design, 
conduct and reporting, and existing CONSORT should be updated regularly, as the field is 
constantly evolving.
Keywords: randomized trials, survey, eMedia, information technology, schizophrenia, 
methodology
Background
The use of technology to advance psychological treatment is a developing professional 
reality.1 The digital revolution has the potential to transform mental health care by 
connecting patients, services and health data in new ways.2 There has been extensive 
research on the use of electronic Media (eMedia) technologies for a variety of emotional 
and mental health problems. A number of literature reviews of interventions delivered 
through eMedia have been published. These include reviews of interventions for anxi-
ety disorders in adults,3 behavior problems in children,4 treatment of alcohol-related 
problems5 and patient education and support for people with schizophrenia.6
Numerous mobile phone-based telemedicine solutions for remote patient monitor-
ing and disease management in schizophrenia have been tested.7 The eMedia-delivered 
interventions for this population group range from simple telephone reminders to 
attend follow-up appointments8 to complex medication monitoring systems to improve 
compliance.9 The virtual reality (VR) programs are being used to teach people various 
skills, most notably vocational and the social competencies,10,11 but novel approaches 
have been developed to help people with chronic psychotic symptoms.12
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eMedia
eMedia can be defined as the media that use electronics or 
electromechanical energy for end users (audience) to access 
content (this is in contrast to static media, mainly print). The 
eMedia sources most familiar to the general public are video 
recordings, audio recordings, multimedia presentations, 
slide presentations, CD-ROM and online content. Most new 
eMedia are now in a digital Media form (dMedia). Numerous 
terms are used to describe interventions delivered through 
dMedia, including mobile health and mobile psychosocial 
interventions (mPSI) (Table 1).
Reviews in this area address the effects of specific forms 
of eMedia,3,13,14 but we know of no definitive overview of 
how eMedia has been used and described in a defined group 
of randomized controlled trials (RCTs). In order to replicate 
the findings, the interventions should be clearly described. 
This should involve details of their development and ini-
tial testing.15 The CONSORT guidelines recommend that 
in reporting of an RCT, the authors should describe each 
intervention thoroughly, including control interventions. The 
description should allow a clinician to know exactly how to 
administer the intervention that was evaluated in the trial. If 
the control group is to receive treatment-as-usual (TAU), it 
is imperative to describe thoroughly what that constitutes. 
If the control group or intervention group is to receive a 
combination of interventions, these should be thoroughly 
described.16,17
Recently, attempts have been made to modify the CONSORT 
guidelines.18 However, these are not widely used, even though 
it has been claimed that implementing these might improve 
the reporting quality of trials in this area.19 The guidelines 
need to be continuously updated as our understanding of 
the issues surrounding eMedia interventions is constantly 
improving.15,20
By taking an overview of the interventions in a specific 
area it may be possible to highlight areas that need further 
development in this new and exciting development in mental 
health care.
Aims
The aim of this survey was to provide a broad overview of 
the type of eMedia interventions for all randomized trials 
relevant to people with schizophrenia. We also wanted to 
examine whether these interventions are described in details 
using a criterion (for example, existing CONSORT eHealth 
checklist). We did not aim to review the effects of these 
interventions.
Methods
search methods
searched source
On January 6, 2015, we searched the Cochrane Schizophrenia 
Group’s Study-Based Register of Trials and updated this search 
on October 5, 2015. The Cochrane Schizophrenia Group’s 
Register of Trials is kept on Microsoft access-based computer 
program called MeerKat (version 1.6) and is compiled by sys-
tematic searches of major national and international resources 
(including monthly updates of AMED, BIOSIS, CINAHL, 
EMBASE, MEDLINE, PsycINFO, PubMed and registries of 
clinical trials) and their monthly updates, hand-searches, gray 
literature and conference proceedings (for detailed description 
of the register see Group’s Module). There is no language, 
date, document type or publication status limitations for the 
inclusion of records into this register.
search strategy
We used the following search strategy, which has been 
developed based on literature review and consulting with 
the authors of the review:
(*Computer* OR *Internet* OR *Electronic* OR 
*Media* OR *Phone*) in Intervention Field of STUDY 
(418 results).
In such a study-based register, searching the major con-
cept retrieves all the synonym keywords and relevant studies 
because all the studies have already been organized based on 
their interventions and linked to the relevant topics (Table S1 
describes detailed keywords).
Table 1 Overall classification of media to deliver interventions for mental health
human media Therapy delivered by human therapists
Print media Books, journals, magazines, newspapers, workbook, textbooks
Non-print media 1. Projected media: they require a light source for projection (eg, film projector slides)
2. Non-projected media: they do not require light source. They include 3-dimensional 
objects, 2-dimensional objects, prints, charts, models, etc.
electronic media audio media, visual media and audiovisual
This can be further divided into:
1. analog
2. Digital media
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inclusion criteria
We included published randomized or quasi-RCTs using 
any eMedia relevant to people with schizophrenia or 
schizophrenia-like illnesses with at least one outcome 
relevant to that same group of people. We also included 
studies that used social media or the Internet for patient or 
caregiver education. There was no requirement for papers 
to report any particular outcome measure or length of 
follow-up.
By eMedia, we meant media that use electronics or 
electromechanical energy for end users (audience) to access 
content (for example, interventions delivered through [but not 
limited to] mobile phones, tablets, computers, TV or radio). 
Initially, we wanted to classify interventions according to 
the type of media and type of e-platform being used, based 
on information technology (IT) system. IT experts advised 
that the interventions could be classified based on the exten-
sion and file type. However, it might be too complicated for 
health professionals (Table 2). On detailed examination of 
studies, however, we found that only limited information 
was available in the majority of studies on these aspects of 
intervention, and it was impossible to classify on this basis. 
In any event, this was also not clinically relevant and we, 
therefore, decided to classify studies according to the type 
of intervention.
Initial search returned 296 abstracts. Of these, 96 were 
considered irrelevant. All the abstracts were carefully 
inspected. Full paper was obtained for clarification if war-
ranted. Given the lack of consensus criteria for eMedia, we 
adopted a broad definition whereby a paper was included if 
the intervention was deemed to be delivered by an electronic 
medium by the trialist. We also included papers in which the 
trialists did not explicitly mention the intervention, but there 
was evidence that some electronic medium was employed. 
Multiple reports of single trials were grouped to avoid double 
counting. Two authors (FN and SX) held numerous discus-
sions to clarify selection, issues around media categories, 
suitability and classification of studies into groups. The 
selected trials were then grouped by type of intervention, 
and the data on the description of the intervention and size 
of the trial were independently extracted (FN, SX and TM). 
SF was consulted when there was a disagreement and to 
clarify issues. We worked with a team of IT specialists to 
clarify issues around the classification of eMedia types. 
One author (SX) has qualifications in IT and medicine. 
Data were entered into an electronic database. In addition, 
we also inspected published meta-analyses and relevant 
Cochrane reviews. After excluding duplicates, and studies 
not concerning a therapeutic intervention or assessment, we 
finally selected 61 studies.
Results
The 61 studies involved 5,352 people with schizophrenia 
(mean =123, median =87, range =20–507). Studies of this 
type are of increasing in frequency (Figure 1).
These trials used a variety of eMedia (eg, mobile/static 
telephone – calls/messaging/applications [apps], computer 
Table 2 Types of digital media
Extensions Types
3g2 cell phones video
3gp cell phones video
aac audio
asf Video
avi Video
azw interactive video book
divx Video
docx Video book
drc Open source
dsi Nintendo audio media file
epub interactive video book
exe interactive book and some other executable
fla Interactive flash
flv Flash video
jpg Artwork file
m2v Video
m4v Video
mkv Matroska video
mobi interactive book
mov Video
mp2 Video
mp3 audio
mp4 Video/artwork-embedded file
mp4v Video
mpe Video
mpeg Video
mpg Video
mpv Video
ogg Open source
ogv Open source
pdb interactive book
pdf interactive video book
Pkg interactive book
prc interactive book
qt Quicktime
rm real media
rmvb real media
svi samsung format
swf Interactive flash
umd Universal media disc
vob dvd format
webm html5 video
wma audio
wmv Video
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software, web pages) and reported outcomes such as 
adherence, assessment of symptoms, patient education, 
symptom improvements and compliance (Table 3).
We classified the interventions according to the target 
areas into the following types:
•	 Education and information
•	 Assessment, screening and monitoring
•	 Improved communications
•	 Relapse management/engagement
•	 Specialized interventions
Eleven trials reported testing of eMedia-delivered 
education/information or training (mean =124, median =91, 
range =25–311): four on assessment, screening or symptom 
monitoring (mean =100, median =90, range =24–225), 
another four on communication improvement (mean =221, 
median =165, range =50–507) and six on relapse management 
and engagement (mean =135, median =124, range =47–254). 
However, the largest number of trials (37) focused on testing 
of provision of specialized interventions. These included 
cognitive remediation (CR) (34 RCTs, N=1,833), problem 
solving (one RCT, N=20) and a novel cognitive behaviour 
therapy [CBT]-based Avatar therapy (one RCT, N=26).
TAU was the most common control group. Only a small 
number of studies compared the intervention with an active 
control (eg, an educational training video compared with a 
non-educational control video) or with a real-life intervention 
(eg, VR job skills training compared with the therapist-delivered 
group). Only two studies compared the same intervention deliv-
ered through a different eMedia (eg, SMS-delivered problem 
solving compared with telephone-delivered problem solving). 
None of the trials surveyed in this study mentioned the use of 
CONSORT-eHEALTH checklist. These papers did not describe 
the interventions in details using an existing criterion. Although 
a significant minority of studies reported feasibility of the 
interventions (n=12), none reported end user experience. None 
of the trials reported participants’ level of digital literacy.20
Discussion
Nearly half (n=35) of the studies reported the use of 
computer programs for CR. Trials of eMedia-delivered 
interventions are increasing in frequency. Studies that may 
have seemed unusual a decade ago are now much more 
common.
Most studies are small (please note the lower end of the 
range of numbers in “Results” section). We recognize that 
many were undertaken by researchers working on very low 
budgets, and power calculations may have been uninforma-
tive when there is little to base them on. Now this does not 
apply. There are studies albeit small. More informative power 
calculations are possible, and we suggest that these should 
be for outcomes that end users designate as important. Even 
if studies of the exact eMedia do not exist, those proposing 
to undertake such trials should be able to extrapolate from 
other good evidence – even if the original intervention was 
not delivered by eMedia.
To our knowledge, this is the first literature survey report-
ing an overview of eMedia-delivered interventions for 
schizophrenia. Previous literature reviews have focused 
mainly on the outcome of interventions.3–6,13,21 The eMedia 
interventions, like any other health care intervention, should 
be clearly described so that results can be replicated.15
Types of eMedia
There was a wide variation in the eMedia used. It varied 
from television (TV), radio, telephone and desktop computer 
to game console, smartphones and handheld device. It is not 
possible to classify eMedia due to the variety of file formats. 
On the basis of this survey, currently there are two types of 
media used:
•	 Interactive media (eg, mobile phone apps or websites)
•	 Didactic media (TV, video, etc.)
The survey also highlighted the following types of inter-
ventions that are delivered by eMedia;
Type 1: Intervention delivered by a human therapist 
through a mobile app or a computer program (eg, tele-
phone-delivered problem solving by a therapist, Avatar 
therapy).
Type 2: Intervention based on a manualized, well- 
established therapy delivered through eMedia (eg, MoodGym).
Type 3: Intervention that did not exist before and is not 
underpinned by an existing theoretical framework.
standardizing, regulating, guiding regarding 
the intervention
There is an interest in standardizing interventions in this area 
and have been attempts to establish criteria to self-certify mobile 




         7LPHLQ\HDUV    
1XPEHURI5&7V
SHU\HDU
Figure 1 Number of RCTs over the years (2001–2014).
Abbreviation: rcTs, randomized control trials.
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app development.22 This followed concerns about the lack of 
standardization and risk assessment of medical apps.23,24
The health regulatory agencies have not paid sufficient 
attention to eMedia-delivered interventions, and therefore lim-
ited information and guidance are available for clinicians or end 
users. The US Food and Drug Administration (FDA) released 
guidance recently, focusing primarily on apps that transform 
the mobile platform into a regulated medical device.25 The 
remaining eMedia will be subject to “enforcement discretion”, 
that is, no regulation.26 The Therapeutic Goods Administra-
tion for health care practitioners in Australia provides limited 
guidance.27 Similarly, the British Medicines and Healthcare 
Products Regulatory Agency does not offer concrete advice for 
clinicians or end users. However, the Business Standards Insti-
tution has developed “PAS 277 Health and wellness apps – 
Quality criteria across the life cycle – Code of practice”28 in 
conjunction with Innovate UK (www.innovateuk.gov.uk). The 
purpose of these guidelines is to develop a set of principles that 
health app developers should follow to ensure that their prod-
ucts and services can be trusted by health care professionals 
and the public. This is an important starting point. However, 
with the slow recognition, acceptance and standardization of 
health apps and the fast pace of development, it seems unlikely 
that standards and regulation will keep up with technological 
advancement.29 No trial reported ease (or difficulty) of access 
and use of the eMedia under test.
None of the studies in this survey followed a set of guide-
lines for quality control.27 Having read these studies in detail, 
we remain unclear about the fidelity of most interventions. 
A small number of studies describe the evidence relating to 
the manualized intervention, which is, in their trial, delivered 
through an eMedia (for example, CR trials). A few studies 
gave details of the eMedia developers, and an even smaller 
number gave details of the intervention in the public arena 
(for example, https://www.itareps.com). While some of these 
interventions might be ready to be used in clinical practice 
(eg, ClinTouch), others may well be impractical (eg, Avatar 
therapy) due to cost, training or ease/difficulty of use.
These relatively new interventions present trialists with 
a dilemma of what to use as a comparison. TAU can be 
problematic,30 and most studies using a TAU comparison 
failed to describe adequately what exactly was “usual”. A small 
number of trials employed innovative control groups such as an 
active control using a similar eMedia, a real-life intervention or 
a different eMedia used to deliver the same intervention.
reporting and outcomes
Use of technical (IT) jargon may not make sense to many 
health professionals. This could easily be overcome 
by providing details of the intervention in an online 
supplement or website. Some guidance is available in 
reporting mPSI.15
Outcomes were not clearly of importance to end users. 
Scale-derived measures (for example, scores on Positive and 
Negative Syndrome Scale) are important mostly to research-
ers and are not usual in routine care. While researchers are 
an important constituency for the trial to serve, they are 
not the only one. End users might be more interested in an 
outcome like user experience. It is important that eMedia 
trials do not lose the opportunity to undertake trials that 
are likely to make any effective procedure applicable to 
wide use.29
None of the studies reported on direct or indirect adverse 
effects or on the cost-effectiveness of these interventions (or 
just the cost of the intervention). Effective encouragement 
of taking medications may lead to adverse events. There is 
evidence that psychosocial interventions also cause adverse 
outcomes.31 Delivery through eMedia complicates and 
possibly increases risks. Furthermore, there may be risks 
particular to eMedia such as reduction in social activities or 
even addiction to eMedia.23
There seems to be an underlying assumption in developing 
eMedia-delivered interventions that they are cost-effective 
compared with human media-delivered treatments. No study 
reported cost per unit of intervention or cost-effectiveness. 
The assumption of eMedia being more cost-effective remains 
an assumption.
Criteria
There is an urgent need to set criteria for standardization of 
development, evaluation and reporting of eMedia interven-
tions. It is imperative that uniform processes are followed and 
that criteria for trial reporting are developed in consultation 
with experts in care, evaluation and IT. Recognizing that such 
suggestions must evolve with technology, we suggest that the 
CONSORT statement needs to be constantly updated.
Conclusion
This survey reports numerous areas of weakness in current 
description of eMedia-delivered interventions for schizo-
phrenia. Most notable issues are descriptions of develop-
ment and initial testing and reporting of interventions, their 
theoretical underpinning and their side effects. There is also a 
need to improve reporting end user experience and adapting 
interventions to their digital or e-literacy skills. None of the 
trials reported use of CONSORT eHealth. Updating these 
guidelines, especially for psychosocial interventions, might 
be the way forward.
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